Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Assessing risk/benefit for trials using preclinical evidence: a proposal
- Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review
- Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
- A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial
- Moving towards less biased research
- Large scale clinical trials: lessons from the COVID-19 pandemic
- Early phase clinical trials extension to guidelines for the content of statistical analysis plans
- Protocol for the systematic review of the reporting of transoral robotic surgery
- Research made simple: ethics committee approval
- Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database